ES2190076T3 - Composiciones medicamentosas contra el helicobacter pylori. - Google Patents

Composiciones medicamentosas contra el helicobacter pylori.

Info

Publication number
ES2190076T3
ES2190076T3 ES98919598T ES98919598T ES2190076T3 ES 2190076 T3 ES2190076 T3 ES 2190076T3 ES 98919598 T ES98919598 T ES 98919598T ES 98919598 T ES98919598 T ES 98919598T ES 2190076 T3 ES2190076 T3 ES 2190076T3
Authority
ES
Spain
Prior art keywords
helicobacter pylori
prevention
infection
pharmaceutical composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98919598T
Other languages
English (en)
Inventor
Masato Watanabe
Kouichi Tanaka
Masayuki Komiya
Ratna Rantiatmodjo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
P T KALBE FARMA
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
P T KALBE FARMA
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P T KALBE FARMA, Yamanouchi Pharmaceutical Co Ltd filed Critical P T KALBE FARMA
Application granted granted Critical
Publication of ES2190076T3 publication Critical patent/ES2190076T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición farmacéutica anti Helicobacter pylori que contiene una derivado de la 1-hidroxy-3-metil-quinolona, representado por la siguiente fórmula (I) o una sal farmacéuticamente aceptable como ingrediente activo.Al mostrar una acción bactericida contra el Helicobacter pylori, esta invención resulta efectiva para el tratamiento o la prevención de la infección por Helicobacter pylori en humanos y otras infecciones relacionadas con una bacteria que pertenezca al género Helicobacter en animales. Además, la composición farmacéutica antiHelicobacter pylori de la presente invención es útil para la prevención (incluyendo la prevención de recaídas) o el tratamiento de enfermedades de los órganos digestivos superiores, como úlceras pépticas (por ejemplo, úlceras gástricas o duodenales), inflamaciones (por ejemplo gastritis o duodenitis aguda o crónica) y cáncer gástrico, así como MALT (tejido linfático asociado a las mucosas) linfoma o enfermedades coronarias crónicas.
ES98919598T 1997-05-16 1998-05-14 Composiciones medicamentosas contra el helicobacter pylori. Expired - Lifetime ES2190076T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12746297 1997-05-16

Publications (1)

Publication Number Publication Date
ES2190076T3 true ES2190076T3 (es) 2003-07-16

Family

ID=14960536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98919598T Expired - Lifetime ES2190076T3 (es) 1997-05-16 1998-05-14 Composiciones medicamentosas contra el helicobacter pylori.

Country Status (10)

Country Link
US (1) US6184230B1 (es)
EP (1) EP0992241B1 (es)
KR (1) KR100512516B1 (es)
CN (1) CN1305472C (es)
AT (1) ATE230264T1 (es)
AU (1) AU7237698A (es)
CA (1) CA2290549C (es)
DE (1) DE69810474T2 (es)
ES (1) ES2190076T3 (es)
WO (1) WO1998051306A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207930A (pt) * 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas lìquidas com sabor mascarado
DE60233874D1 (de) 2001-06-22 2009-11-12 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
AU2003268672A1 (en) * 2002-09-26 2004-04-19 Yamanouchi Pharmaceutical Co., Ltd. Drug absorbability improving agents
TWI463998B (zh) * 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
EP3336081B1 (en) * 2013-02-26 2019-05-01 Microbial Chemistry Research Foundation Novel compound, production method therefor, and use of said compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07189Y2 (ja) * 1987-08-19 1995-01-11 有限会社平伊建機 自走行式クラッシャ−
JP2574489B2 (ja) * 1988-12-17 1997-01-22 明治製菓株式会社 ２，３―ジ置換―４―ヒドロキシキノリン誘導体及びその製法
JPH05117268A (ja) * 1991-10-22 1993-05-14 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
JP3117294B2 (ja) * 1992-08-10 2000-12-11 山之内製薬株式会社 新規抗生物質及びその製造法
WO1997012868A1 (en) * 1995-09-29 1997-04-10 Pfizer Pharmaceuticals Inc. Quinolone compounds for the treatment of disorders caused by helicobacter pylori
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives

Also Published As

Publication number Publication date
KR100512516B1 (ko) 2005-09-06
KR20010012572A (ko) 2001-02-15
CA2290549C (en) 2007-04-17
EP0992241A4 (en) 2001-04-04
CN1305472C (zh) 2007-03-21
ATE230264T1 (de) 2003-01-15
DE69810474D1 (de) 2003-02-06
EP0992241B1 (en) 2003-01-02
AU7237698A (en) 1998-12-08
DE69810474T2 (de) 2003-10-30
EP0992241A1 (en) 2000-04-12
WO1998051306A1 (fr) 1998-11-19
CN1255853A (zh) 2000-06-07
US6184230B1 (en) 2001-02-06
CA2290549A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
HK1094191A1 (en) Phenyl-carboxamide compounds useful for treating pain
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
IL154536A0 (en) Immunoregulatory compounds and derivatives and methods of treating diseases therewith
RU99107569A (ru) Фармацевтические композиции, обладающие антимикробной активностью
AU2002357191A1 (en) Derivatives of isoindigo, indigo and indirubin and use in treating cancer
FI933681A0 (fi) Antimikrobiellt medel
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ES2190076T3 (es) Composiciones medicamentosas contra el helicobacter pylori.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
KR20010024050A (ko) 항균제
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
BR0011666A (pt) Derivado de pirrolpiridazina opticamente ativo ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso em derivado de pirrolpiridazina opticamente ativo, método para tratar ou prevenir doença e, processo para sintetizar um derivado de pirrolpiridazina opticamente ativo ou um sal farmaceuticamente aceitável do mesmo
RU95110774A (ru) Олигонуклеотиды, терапевтические композиции, применение композиций
EP1560578B1 (fr) Utilisation du sel distrontique de l'acide 2-¬n,n-di(carboxymethyl)amino|-3-cyano-4-carboxymethyl-thiophène-5-carboxylique pour l'obtention de médicaments destinés au traitement des douleurs gastro-duodénales
AU5526499A (en) Ingestible compositions comprising antibacterial agents
WO2023038522A1 (en) Compositions and methods for treating biofilm disorders and infection
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
KR890001555A (ko) 요산 배설용 조성물
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
TH69069A (th) การรักษาแมลงรบกวนในสัตว์เลี้ยงโดยการให้ทางปาก
TH32073A (th) กรรมวิธีสำหรับการป้องกันและรักษาอาการผิดปกติที่เกี่ยวข้องกับระบบกระเพาะอาหารและลำใส้